Table 2.
Lidocaine (n = 30) | Levo-bupivacaine (n = 30) | Placebo (n = 30) | |
Surgery HV/comb | 28/2 | 26/4 | 27/3 |
Duration of surgery (min.) | 12.4 ± 2.1 | 12.4 ± 2.7 | 11.9 ± 1.6 |
Propofol (mg) | 104 ± 36 | 106 ± 38 | 115 ± 31 |
Et Sevo peak (%) | 1.38 ± 0.55 | 1.42 ± 0.40 | 1.85 ± 0.67 ** |
Et Sevo mean (%) | 0.99 ± 0.35 | 1.03 ± 0.26 | 1.43 ± 0.45 ** |
OAAS 5 (min.) | 8 ± 3 | 8 ± 3 | 8 ± 3 |
Discharge (min.) | 40 ± 8 | 40 ± 9 | 42 ± 9 |
** p < 0.01 ANOVA
HV Hallux Valgus
Et Sevo end tidal concentration of sevoflurane
OAAS Observer Assessment of Alertness Scale (5 awake, 0 asleep not responding to noxious stimulation).